- Home
- GLNG vs KTTA Comparison
GLNG vs KTTA Comparison
Compare GLNG & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLNG
- KTTA
- Stock Information
- Founded
- GLNG 1946
- KTTA 2020
- Country
- GLNG Bermuda
- KTTA United States
- Employees
- GLNG N/A
- KTTA N/A
- Industry
- GLNG Marine Transportation
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- GLNG Consumer Discretionary
- KTTA Health Care
- Exchange
- GLNG Nasdaq
- KTTA Nasdaq
- Market Cap
- GLNG 4.1B
- KTTA 2.8M
- IPO Year
- GLNG N/A
- KTTA 2021
- Fundamental
- Price
- GLNG $41.16
- KTTA $0.97
- Analyst Decision
- GLNG Strong Buy
- KTTA
- Analyst Count
- GLNG 5
- KTTA 0
- Target Price
- GLNG $48.70
- KTTA N/A
- AVG Volume (30 Days)
- GLNG 2.0M
- KTTA 13.9M
- Earning Date
- GLNG 01-01-0001
- KTTA 05-15-2025
- Dividend Yield
- GLNG 2.43%
- KTTA N/A
- EPS Growth
- GLNG N/A
- KTTA N/A
- EPS
- GLNG 0.03
- KTTA N/A
- Revenue
- GLNG $257,915,000.00
- KTTA N/A
- Revenue This Year
- GLNG $70.72
- KTTA N/A
- Revenue Next Year
- GLNG N/A
- KTTA N/A
- P/E Ratio
- GLNG $1,128.48
- KTTA N/A
- Revenue Growth
- GLNG N/A
- KTTA N/A
- 52 Week Low
- GLNG $25.33
- KTTA $0.79
- 52 Week High
- GLNG $44.36
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- GLNG 58.21
- KTTA 43.16
- Support Level
- GLNG $36.72
- KTTA $0.79
- Resistance Level
- GLNG $42.42
- KTTA $0.94
- Average True Range (ATR)
- GLNG 1.35
- KTTA 0.11
- MACD
- GLNG 0.19
- KTTA 0.01
- Stochastic Oscillator
- GLNG 77.89
- KTTA 53.22
About GLNG Golar Lng Ltd
Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).